Post by
bikkel78 on Oct 05, 2022 2:52am
Put pressure on the company
Sad to see they made the decision to save the prelim DLBCL data for a conference. Seems like they prefer scientists over shareholders. Time for action. Please send a mail to ddavan@imv-inc.com or other memebers of management expressing your feelings.
Comment by
europe10 on Oct 11, 2022 3:10pm
Several trials are "open"? Right? So it points towards medicore results? Expect 10:1 reversed split and a huge financing